Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (281-290 of 546) with videos related to

Pageof 55
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lungEsther Schirrmacher, Ralf Schirrmacher, Oliver Thews, et al.
EJNMMI Physics|March 12, 2021
Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&TJulia Brosch-Lenz, Carlos Uribe, Astrid Gosewisch, et al.
The American Journal of Psychiatry|August 2, 2005
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patientsAndreas Heinz, Thomas Siessmeier, Jana Wrase, et al.
Advances in Radiation Oncology|March 10, 2023
High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With <sup>18</sup>F-GE-180Daniel Felix Fleischmann, Marcel Büttner, Marcus Unterrainer, et al.
Biological Psychiatry|June 18, 2011
Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delayStefan Förster, Timo Grimmer, Isabelle Miederer, et al.
Epilepsia|August 23, 2006
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET studyKonrad J Werhahn, Christian Landvogt, Sven Klimpe, et al.
Zeitschrift Fur Medizinische Physik|January 22, 2023
Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patientsArtem Zatcepin, Anna Kopczak, Adrien Holzgreve, et al.
Oncotarget|November 16, 2017
Salvage lymph node dissection after <sup>68</sup>Ga-PSMA or <sup>18</sup>F-FEC PET/CT for nodal recurrence in prostate cancer patientsAnnika Herlemann, Alexander Kretschmer, Alexander Buchner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2019
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic <sup>18</sup>F-FET PETFranziska Vettermann, Bogdana Suchorska, Marcus Unterrainer, et al.
Radiation Oncology (London, England)|March 4, 2018
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomyNina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, et al.
Pageof 55

Showing results (281-290 of 546) with videos related to

Sort By:
Pageof 55
Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Synthesis and preliminary evaluation of (R,R)(S,S) 5-(2-(2-[4-(2-[(18)F]fluoroethoxy)phenyl]-1-methylethylamino)-1-hydroxyethyl)-benzene-1,3-diol ([(18)F]FEFE) for the in vivo visualisation and quantification of the beta2-adrenergic receptor status in lungEsther Schirrmacher, Ralf Schirrmacher, Oliver Thews, et al.
EJNMMI Physics|March 12, 2021
Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&TJulia Brosch-Lenz, Carlos Uribe, Astrid Gosewisch, et al.
The American Journal of Psychiatry|August 2, 2005
Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patientsAndreas Heinz, Thomas Siessmeier, Jana Wrase, et al.
Advances in Radiation Oncology|March 10, 2023
High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With <sup>18</sup>F-GE-180Daniel Felix Fleischmann, Marcel Büttner, Marcus Unterrainer, et al.
Biological Psychiatry|June 18, 2011
Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delayStefan Förster, Timo Grimmer, Isabelle Miederer, et al.
Epilepsia|August 23, 2006
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET studyKonrad J Werhahn, Christian Landvogt, Sven Klimpe, et al.
Zeitschrift Fur Medizinische Physik|January 22, 2023
Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patientsArtem Zatcepin, Anna Kopczak, Adrien Holzgreve, et al.
Oncotarget|November 16, 2017
Salvage lymph node dissection after <sup>68</sup>Ga-PSMA or <sup>18</sup>F-FEC PET/CT for nodal recurrence in prostate cancer patientsAnnika Herlemann, Alexander Kretschmer, Alexander Buchner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 15, 2019
Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic <sup>18</sup>F-FET PETFranziska Vettermann, Bogdana Suchorska, Marcus Unterrainer, et al.
Radiation Oncology (London, England)|March 4, 2018
Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomyNina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, et al.
Pageof 55